Our laboratory seeks to identify gene expression and serum protein signatures that distinguish SLE patients from healthy controls or that predict disease activity or other clinical outcomes of SLE. We also aim to identify genetic variants that influence the expression of these molecular signatures.
Current lab members include:
Emily Baechler Gillespie, Ph.D.
Hatice Bilgic, Ph.D.
Theresa Wampler Muskardin, M.D.